The last decade has seen vast improvements in humanoid robots, but graduating to widespread use might require going back to the fundamentals. “Not reliably,” Hurst said. “I don’t think it’s totally ...

For Andrew Hall, a veteran of Big Pharma-turned biotech builder, he has spent much of his recent career operating inside those constraints — and learning how to lead through them. Today, as CEO of ...

G&A Expenses -- $13.8 million in the fourth quarter, of which $5.6 million was non-cash stock-based compensation; annual G&A ...

This is an audio transcript of The Economics Show podcast episode: ‘Is AI (finally) making us more productive? With John Burn-Murdoch and Sarah O’Connor’ Soumaya Keynes I have read a lot of science ...

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2025 Earnings Call Transcript March 12, 2026 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.22551.

Affinity combines a comprehensive set of photo editing, page layout, and vector illustration tools into a single, free app, ...

Have you ever tried mixing oil and water? That is the moment software architecture is entering as deterministic systems meet non deterministic AI behaviour. Architects must anchor intelligent systems ...

A comparative evaluation indicates that climate anomalies over the past three years have been particularly severe. The rise in temperatures in certain regions, alongside unprecedented climate ...